➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
McKesson
Johnson and Johnson
Dow
Moodys

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

AMICAR Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Amicar, and when can generic versions of Amicar launch?

Amicar is a drug marketed by Clover Pharms and is included in three NDAs.

The generic ingredient in AMICAR is aminocaproic acid. There are six drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the aminocaproic acid profile page.

US ANDA Litigation and Generic Entry Outlook for Amicar

A generic version of AMICAR was approved as aminocaproic acid by LUITPOLD on December 1st, 1987.

  Start Trial

Drug patent expirations by year for AMICAR
Drug Prices for AMICAR

See drug prices for AMICAR

Recent Clinical Trials for AMICAR

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Universidad Autonoma de Nuevo LeonPhase 2
The University of Texas Health Science Center at San AntonioPhase 1
Duke UniversityPhase 4

See all AMICAR clinical trials

Pharmacology for AMICAR
Drug ClassAntifibrinolytic Agent
Physiological EffectDecreased Fibrinolysis

US Patents and Regulatory Information for AMICAR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Clover Pharms AMICAR aminocaproic acid INJECTABLE;INJECTION 015229-002 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Clover Pharms AMICAR aminocaproic acid TABLET;ORAL 015197-001 Approved Prior to Jan 1, 1982 AB RX Yes No   Start Trial   Start Trial   Start Trial
Clover Pharms AMICAR aminocaproic acid SYRUP;ORAL 015230-002 Approved Prior to Jan 1, 1982 AA RX Yes Yes   Start Trial   Start Trial   Start Trial
Clover Pharms AMICAR aminocaproic acid TABLET;ORAL 015197-002 Jun 24, 2004 AB RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
McKesson
Johnson and Johnson
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.